New methodologies for the estimation of population vulnerability to diseases: A case study of Lassa fever and Ebola in Nigeria and Sierra Leone

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 374, Issue 1776, 2019, Pages

  Kajero, Olumayowa ^a   Del Rio Vilas, Victor ^a   Wood, James L N ^b   Iacono, Giovanni Lo ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adaptive capacity; Impact; Mathematical modelling; Zoonosis

Indexed keywords

BIOINDICATOR; DISEASE PREVALENCE; EBOLA VIRUS DISEASE; HEALTH IMPACT; HETEROGENEITY; INFECTIOUS DISEASE; METHODOLOGY; MORBIDITY; NATURAL HAZARD; NUMERICAL MODEL; POPULATION ESTIMATION; PUBLIC HEALTH; VULNERABILITY;

NIGERIA; SIERRA LEONE;

ANIMALIA;

EID: 85065404899     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2018.0265     Document Type: Article

References (59)

1. Fleming L et al. 2018 Beyond climate change and health: integrating broader environmental change and natural environments for public health protection and promotion in the UK. Atmosphere 9, 245. (doi:10.3390/atmos9070245)
2. Whitmee S et al. 2015 Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health. Lancet 386, 1973-2028. (doi:10. 1016/S0140-6736(15)60901-1)
3. Moore M, Gelfeld B, Okunogbe A, Paul C. 2016 Identifying future disease hot spots: infectious disease vulnerability index, vol. 6. Santa Monica, CA: RAND Corporation. ISBN 9780833095749.
4. Adger WN. 2006 Vulnerability. Glob. Environ. Change 16, 268-281. (doi:10.1016/j.gloenvcha. 2006.02.006)
5. Gallopín GC. 2006 Linkages between vulnerability, resilience, and adaptive capacity. Glob. Environ. Change 16, 293-303. (doi:10.1016/j.gloenvcha. 2006.02.004)
6. Suk JE, Ebi KL, Vose D, Wint W, Alexander N, Mintiens K, Semenza JC. 2014 Indicators for tracking European vulnerabilities to the risks of infectious disease transmission due to climate change. Int. J. Environ. Res. Public Health 11, 2218-2235. (doi:10.3390/ijerph110202218)
7. Bates I, Fenton C, Gruber J, Lalloo D, Lara AM, Squire SB, Theobald S, Thomson R, Tolhurst R. 2004 Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: household level. Lancet Infect. Dis. 4, 267-277. (doi:10.1016/s1473-3099(04)01002-3)
8. Briand S et al. 2009 Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach. PLOS Negl. Trop. Dis. 3, 1-9. (doi:10. 1371/journal.pntd.0000483)
9. Hagenlocher M, Castro MC. 2015 Mapping malaria risk and vulnerability in the United Republic of Tanzania: a spatial explicit model. Popul. Health Metrics 13, 2. (doi:10.1186/s12963-015-0036-2)
10. Semenza JC, Suk JE, Estevez V, Ebi KL, Lindgren E. 2011 Mapping climate change vulnerabilities to infectious diseases in Europe. Environ. Health Perspect. 120, 385-392. (doi:10.1289/ehp.1103805)
11. Semenza JC, Herbst S, Rechenburg A, Suk JE, Höser C, Schreiber C, Kistemann T. 2012 Climate change impact assessment of food- and waterborne diseases. Crit. Rev. Environ. Sci. Technol. 42, 857-890. (doi:10.1080/10643389.2010.534706)
12. Ramirez B. 2017 Support for research towards understanding the population health vulnerabilities to vector-borne diseases: increasing resilience under climate change conditions in Africa. Infect. Dis. Poverty 6, 164. (doi:10.1186/s40249-017-0378-z)
13. Kucharski AJ, Camacho A, Flasche S, Glover RE, Edmunds WJ, Funk S. 2015 Measuring the impact of Ebola control measures in Sierra Leone. Proc. Natl Acad. Sci. USA 112, 14 366-14 371. (doi:10.1073/ pnas.1508814112)
14. Weitz JS, Dushoff J. 2015 Modeling post-death transmission of Ebola: challenges for inference and opportunities for control. Sci. Rep. 5, 1-7. (doi:10. 1038/srep08751)
15. Redding D, Atkinson P, Cunningham A, Iacono GL, Moses L, Wood J, Jones K. 2017 Impact of global change on future Ebola emergence and epidemic potential in Africa. bioRxiv 206169. (doi:10.1101/ 206169)
16. Medlock JM, Hansford KM, Schaffner F, Versteirt V, Hendrickx G, Zeller H, Bortel WV. 2012 A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options. Vector Borne Zoonotic Dis. 12, 435-447. (doi:10.1089/vbz.2011.0814)
17. Medlock JM, Leach SA. 2015 Effect of climate change on vector-borne disease risk in the UK. Lancet Infect. Dis. 15, 721-730. (doi:10.1016/ S1473-3099(15)70091-5)
18. Beltrame A et al. 2007 Imported Chikungunya infection, Italy. Emerg. Infect. Dis. 13, 1264-1266. (doi:10.3201/eid1308.070161)
19. Rezza G et al. 2007 Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370, 1840-1846. (doi:10.1016/S0140-6736(07)61779-6)
20. La Ruche G et al. 2010 First two autochthonous dengue virus infections in metropolitan France, September 2010. Eurosurveillance 15, 19676.
21. Gjenero-Margan I et al. 2011 Autochthonous dengue fever in Croatia, August-September 2010. Euro surveillance: bulletin Européen sur les maladies transmissibles ¼ European communicable disease bulletin 16. 19805.
22. European Centre for Disease Prevention and Control, 2012 Mission report. Dengue outbreak in Madeira, Portugal. Technical Report October-November, European Centre for Disease Prevention and Control (ECDC). (doi:10.2900/75830)
23. Tomasello D, Schlagenhauf P. 2013 Chikungunya and dengue autochthonous cases in Europe, 2007-2012. Travel Med. Infect. Dis. 11, 274-284. (doi:10. 1016/j.tmaid.2013.07.006)
24. Poland GA, Jacobson RM. 2001 Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine 19, 2440-2445. (doi:10.1016/S0264-410X(00)00469-2)
25. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. 2008 Global trends in emerging infectious diseases. Nature 451, 990-993. (doi:10.1038/nature06536)
26. Pigott DM et al. 2014 Mapping the zoonotic niche of Ebola virus disease in Africa. eLife 3, e04395. (doi:10.7554/eLife.04395)
27. Mylne AQN et al. 2015 Mapping the zoonotic niche of Lassa fever in Africa. Trans. R Soc. Trop. Med. Hyg. 5, 1-10. (doi:10.1093/trstmh/trv047)
28. Pigott DM et al. 2016 Updates to the zoonotic niche map of Ebola virus disease in Africa. eLife 5, e16412 (doi:10.7554/eLife.16412)
29. Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A. 2007 Understanding the dynamics of Ebola epidemics. Epidemiol. Infect. 135, 610-621. (doi:10.1017/S0950268806007217)
30. Leroy EM et al. 2005 Fruit bats as reservoirs of Ebola virus. Nature 438, 575-576. (doi:10.1038/438575a)
31. Leendertz S. 2016 Testing new hypotheses regarding Ebolavirus reservoirs. Viruses 8, 30. (doi:10.3390/v8020030)
32. Kiskowski M. 2014 A three-scale network model for the early growth dynamics of 2014 West Africa Ebola epidemic. PLOS Curr. Outbreaks 2014 Nov 13, Edition 1. (doi:10.1371/currents.outb reaks.c6efe8274dc55274f05cbcb62bbe6070)
33. Chowell G, Hengartner N, Castillo-Chavez C, Fenimore P, Hyman J. 2004 The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J. Theor. Biol. 229, 119-126. (doi:10.1016/j.jtbi.2004.03.006)
34. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. 1987 A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155, 437-444. (doi:10.1093/infdis/155.3.437)
35. Lo Iacono G et al. 2015 Using modelling to disentangle the relative contributions of zoonotic and Anthroponotic transmission: the case of Lassa fever. PLOS Negl. Trop. Dis. 9, e3398. (doi:10.1371/ journal.pntd.0003398)
36. Frame JD, Baldwin JM, Gocke DJ, Troup JM. 1970 Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg. 19, 670-676. (ISSN 0002-9637)
37. Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A. 1974 Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185, 263-265. (doi:10.1126/ science.185.4147.263)
38. Olayemi A et al. 2016 New hosts of the Lassa virus. Sci. Rep. 6, 25280. (doi:10.1038/srep25280)
39. Siddle KJ et al. 2018 Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018. N. Engl. J. Med. 379, 1745-1753. (doi:10.1056/ NEJMoa1804498)
40. Kafetzopoulou LE et al. 2019 Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 363, 74-77. (doi:10. 1126/science.aau9343)
41. Anonymous. CDC Facts sheet. Available at: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lassaf.htm. Retrieved 05/09/2011.
42. Pindyck RS. 2017 The use and misuse of models for climate policy. Rev. Environ. Econ. Policy 11, 100-114. (doi:10.1093/reep/rew012)
43. Del Rio Vilas VJ, Voller F, Montibeller G, Franco LA, Sribhashyam S, Watson E, Hartley M, Gibbens JC. 2013 An integrated process and management tools for ranking multiple emerging threats to animal health. Prev. Vet. Med. 108, 94-102. (doi:10.1016/ j.prevetmed.2012.08.007)
44. Lo Iacono G et al. 2016 A unified framework for the infection dynamics of zoonotic spillover and spread. PLOS Negl. Trop. Dis. 10, e0004957. (doi:10.1371/ journal.pntd.0004957)
45. Perlman S, McCray PB. 2013 Person-to-person spread of the MERS coronavirus - an evolving picture. N. Engl. J. Med. 369, 466-467. (doi:10. 1056/NEJMe1308724)
46. Goba A et al. 2016 An outbreak of Ebola virus disease in the Lassa fever zone. J. Infect. Dis. 214, S110-S121. (doi:10.1093/infdis/jiw239)
47. Mertens T, Hayes R, Smith P. 1990 Epidemiological methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS 4, 57-65. (doi:10.1097/00002030-199001000-00008)
48. Price RM, Bonett DG. 2000 Estimating the ratio of two Poisson rates. Comput. Stat. Data Anal. 34, 345-356. (doi:10.1016/S0167-9473(99)00100-0)
49. Anonymous. Knoema. Available at: https://knoema.com/. Retrieved: 14/05/2018.
50. Anonymous. The humanitarian data exchange. Available at: https://data.humdata.org/. Retrieved: 15/05/2018.
51. Anonymous. Global Health Observatory data repository. Available at: http://apps.who.int/gho/data/node.home. Retrieved: 15/05/2018.
52. Sutherst RW. 2004 Global change and human vulnerability to vector-borne diseases. Clin. Microbiol. Rev. 17, 136-173. (doi:10.1128/CMR.17. 1.136-173.2004)
53. Bardosh KL, Ryan S, Ebi K, Welburn S, Singer B. 2017 Addressing vulnerability, building resilience: community-based adaptation to vector-borne diseases in the context of global change. Infect. Dis. Poverty 6, 166. (doi:10.1186/s40249-017-0375-2)
54. Grant C, Lo Iacono G, Dzingirai V, Bett B, Winnebah TRA, Atkinson PM. 2016 Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in Africa. Infect. Dis. Poverty 5, 17. (doi:10.1186/ s40249-016-0110-4)
55. Scoones I, Jones K, Lo Iacono G, Redding DW, Wilkinson A, Wood JLN. 2017 Integrative modelling for One Health: pattern, process and participation. Phil. Trans. R. Soc. B 372, 20160164. (doi:10.1098/ rstb.2016.0164)
56. Kleinbaum DG, Klein M. 2005 Survival analysis: a self-learning text. Berlin, Germany: Springer. ISBN 9780387291505
57. Lo Iacono G, Armstrong B, Fleming LE, Elson R, Kovats S, Vardoulakis S, Nichols GL. 2017 Challenges in developing methods for quantifying the effects of weather and climate on water-associated diseases: a systematic review. PLOS Negl. Trop. Dis. 11, e0005659. (doi:10.1371/journal.pntd.0005659)
58. Lo Iacono G, Nichols GL. 2017 Modeling the impact of environment on infectious diseases. Oxford, UK: Oxford University Press.
59. Lo Iacono G, Cunningham AA, Bett B, Grace D, Redding DW, Wood JLN. 2018 Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models. Proc. Natl Acad. Sci. USA E7448-E7456. (doi:10.1073/pnas. 1803264115)